跳至主要内容
临床试验/CTRI/2019/03/018184
CTRI/2019/03/018184已完成1/2 期

Randomized controlled clinical trial to study the effect of Vasaghrita Aschyotana and Calcium Chloride eyedrop in Kaphaj Timir

Sane Guruji Arogya Kendra1 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2019年1月4日最近更新:

试验速览

阶段
1/2 期
状态
已完成
入组人数
70
试验地点
1
主要终点
A comparative clinical study to evaluate efficasy of Vasaghrita Aschyotana and Calcium Chloride eye drop in Kaphaj Timir

研究概览

简要总结

This study is open labelled randomized controlled clinical trial to evaluate the effect of Vasaghrit Aschyotan applied twice daily for 45 days in comparison with calcium chloride eye drops in eye/ eyes of patients affected with Kaphaj Timir. The Primary outcome will be effect of Vasaghrita Aschyotan and the secondary outcome will be the delay in maturity of senile immature cataract.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
Open Label

入排标准

年龄范围
50.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • Patients suffering from symptoms of Kaphaja Timira.
  • Patients of age group 50 to 70 yrs.
  • Patients of either gender will be included in the study.
  • Visual acuity of 6/12 or less.

排除标准

  • Mature and Hypermature cataract.
  • Congenital, traumatic, complicated & metabolic cataract.
  • Any ocular pathology that can cause diminution of vision.

结局指标

主要结局

A comparative clinical study to evaluate efficasy of Vasaghrita Aschyotana and Calcium Chloride eye drop in Kaphaj Timir

时间窗: The drug will be given 45 days. The patients will be assessed before and after treatment. Total duratin of the study will 18 months.

次要结局

  • Delay in maturity of senile immature cataract.(18 months)

研究者

申办方类型
Research institution and hospital

研究点 (1)

Loading locations...

相似试验